Page last updated: 2024-08-21

dihydroergotamine and oxadiazoles

dihydroergotamine has been researched along with oxadiazoles in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fiedler, VB; Göbel, H; Nitz, RE1
John, GW; Le Grand, B; Vié, B1
Centurión, D; De Vries, P; Rabelo, G; Sánchez-López, A; Saxena, P; Villalón, CM1
Centurión, D; Cobos-Puc, LE; González-Hernández, A; Lozano-Cuenca, J; Muñoz-Islas, E; Pertz, HH; Sánchez-López, A; Villalón, CM1
Altamirano-Espinoza, AH; González-Hernández, A; MaassenVanDenBrink, A; Manrique-Maldonado, G; Marichal-Cancino, BA; Ruiz-Salinas, II; Villalón, CM1

Other Studies

5 other study(ies) available for dihydroergotamine and oxadiazoles

ArticleYear
Effects of dihydroergotamine on hemodynamic molsidomine actions in anesthetized dogs.
    Canadian journal of physiology and pharmacology, 1984, Volume: 62, Issue:6

    Topics: Anesthesia; Animals; Cardiac Output; Cardiovascular Diseases; Dihydroergotamine; Dogs; Drug Interactions; Female; Hemodynamics; Male; Molsidomine; Oxadiazoles; Stroke Volume; Sydnones; Time Factors

1984
Effects of sumatriptan on coronary flow and left ventricular function in the isolated perfused guinea pig heart.
    Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:3

    Topics: Animals; Coronary Circulation; Diastole; Dihydroergotamine; Endothelium, Vascular; Guinea Pigs; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Oxadiazoles; Oxazoles; Oxazolidinones; Perfusion; Piperazines; Rabbits; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Ventricular Function, Left

1998
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    British journal of pharmacology, 1999, Volume: 126, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Flow Velocity; Carotid Arteries; Clonidine; Dihydroergotamine; Dogs; Ergotamine; Female; Hemodynamics; Male; Methysergide; Oxadiazoles; Phenylephrine; Piperazines; Prazosin; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin Antagonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Yohimbine

1999
Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
    European journal of pharmacology, 2009, Jun-10, Volume: 612, Issue:1-3

    Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Blood Pressure; Decerebrate State; Dihydroergotamine; Dose-Response Relationship, Drug; Drug Combinations; Electric Stimulation; Heart Rate; Hemodynamics; Male; Methysergide; Norepinephrine; Oxadiazoles; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic, alpha-2; Serotonin Antagonists; Sympathetic Nervous System; Tachycardia; Yohimbine

2009
Intrathecal dihydroergotamine inhibits capsaicin-induced vasodilatation in the canine external carotid circulation via GR127935- and rauwolscine-sensitive receptors.
    European journal of pharmacology, 2012, Oct-05, Volume: 692, Issue:1-3

    Topics: Acetylcholine; Animals; Blood Circulation; Calcitonin Gene-Related Peptide; Capsaicin; Carotid Arteries; Dihydroergotamine; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Injections, Spinal; Male; Oxadiazoles; Piperazines; Propylene Glycol; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Antagonists; Vasodilation; Vasodilator Agents; Yohimbine

2012